Best Healthcare Stocks — The YouTuber Consensus
Which healthcare and biotech stocks do finance YouTubers recommend with real analysis? This list ranks the consensus across the sector.
“The YouTuber is buying Transmedics, believing it to be a cheap growth stock with significant upside. He bases …”
“Eli Lilly is presented as a high-conviction buy, poised to be the first trillion-dollar healthcare company, dr…”
“The YouTuber's highest conviction pick is Hims and Hers, viewing it as a disruptive healthcare aggregator that…”
“The YouTuber highly recommends Topicus, citing its high growth rates, shareholder-friendly approach (no stock-…”
“The YouTuber recommends Amgen for its 2.9% dividend and strong diversification across sectors. As a large drug…”
“The YouTuber suggests Stryker as a long-term buy due to its stock being down approximately 20% over the past y…”
“The YouTuber suggests buying Compass Pathways as a calculated speculation due to its potential for significant…”
“The YouTuber recommends Integrys for its supply of ultra-pure chemicals and materials essential for advanced c…”
“The YouTuber identifies Adaptive Biotech Technologies (ADPT) as a potential 10x stock by 2030, based on a patt…”
“The YouTuber suggests buying the Healthcare Select Sector ETF (XLV) because the sector has lagged this year bu…”
“The YouTuber explains Michael Burry's 'fat pitch' assessment of Zoetis, an animal medicine company, despite on…”
“The YouTuber is highly excited about 10X Genomics, a leader in spatial biology that allows scientists to under…”
“The YouTuber highlights Viatris as a business with a significantly down stock price but continuously growing p…”
“The analyst suggests Abbott Labs is a good value play despite fears surrounding GLP-1 drugs impacting its card…”
“The YouTuber views Oscar Health as a disruptive force in the health insurance market, specifically within the …”
“The YouTuber recommends ATAI Life Sciences as a 'diversified play' in the psychedelic therapy market. Unlike C…”
“The YouTuber suggests GH Research as a 'technology bet' in the psychedelic therapy sector, focusing on a compo…”
“The analyst sees tremendous upside potential in Owlet, despite its high-risk profile and recent CEO change. He…”
“The YouTuber identifies AbbVie as a top pharmaceutical pick due to its strong pipeline and blockbuster drugs l…”
“The YouTuber recommends Intuitive Surgical as a leader in healthcare robotics, citing its Da Vinci surgical sy…”
“Novo Nordisk's stock plunged due to a lowered sales growth target and concerns over generic competition and dr…”
“The YouTuber argues that Novo Nordisk is significantly undervalued, trading at half the market's price-to-five…”
“The analyst suggests Boston Scientific, noting it did not experience a GLP-1 related sell-off and has no diabe…”
“The YouTuber suggests Align Technologies is a buy due to its current undervaluation, trading at a P/E of aroun…”
“The YouTuber recommends Chemed as a buy, noting its current P/E of 20 is significantly below its historical av…”
“Pfizer is presented as a potential next major player in the weight loss space, with a once-daily pill expected…”
“The YouTuber believes Sanofi is a good buying opportunity due to its current undervaluation, evidenced by a lo…”
“The analyst is watching Novartis as part of a broader shift into energy and healthcare sectors, which are seen…”
“The analyst recommends buying the remaining Johnson & Johnson (Pharma/Medical Devices) after its consumer divi…”
“The YouTuber recommends Insulet Corporation, noting its 25% gain since his previous recommendation, as it sell…”
“The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value r…”
“The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, …”
“The YouTuber states that Elevance is 'extremely cheap' with a value ratio under 10, suggesting it is a good in…”
“The analyst recommends buying CVS Health, citing its strong revenue and EBITDA growth, robust free cash flow, …”
“The analyst believes Walgreens Boots Alliance (WBA) is a buy due to potential catalysts from the sale of its B…”
“The analyst views Dexcom as a potential bargain after a significant stock drop due to a lowered outlook, which…”
“Idex Laboratories, a market leader in animal medicine, has corrected by 40% from its peak, making it significa…”
“The YouTuber suggests Lanthus Holdings is an interesting and potentially cheap stock, trading at a price to fr…”
“The analyst advises against investing in Bayer, citing ongoing issues with Monsanto lawsuits, a negative free …”
“The YouTuber recommends HCA Healthcare as a 'safe stock' during a potential recession. He argues that the heal…”
No data yet — the crawler is running.
Why you can trust the ranking
No hype, no cherry-picking — just qualified calls, weighed evenly across every creator we track.Only qualified calls
A named stock, a clear buy or sell stance, and real reasoning. Passing mentions and hype are filtered out.
One vote per creator
Each channel counts once per stock, so a single loud voice can't skew the ranking.
Weighted consensus
We weigh how many creators agree, how convinced they are, and how recent each call is.
FAQ
How is this ranking calculated?
We crawl finance YouTubers, transcribe their videos, and use AI to extract only qualified analyses (named stock + clear direction + real reasoning). Each channel counts once per stock; the ranking weighs consensus, analysis quality, conviction and recency.
What counts as a qualified signal?
A named stock, a clear buy or sell stance, and real reasoning — valuation, fundamentals, a catalyst or a technical setup. Passing mentions and hype with no argument are ignored.
How often is the data updated?
We crawl the tracked finance YouTubers daily, transcribe new videos, and re-weight the ranking every day — so the most recent, highest-conviction calls rise to the top.
Is BullVox free?
Yes — it's completely free, and every signal links back to the original video as its source.
Is this financial advice?
Not financial advice. This site aggregates third-party opinions (finance YouTubers) for informational purposes. Do not make investment decisions based on this alone.